Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease

被引:0
|
作者
Jung, Han Na [1 ,2 ]
Jung, Chang Hee [1 ,2 ]
机构
[1] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Asan Diabet Ctr, Asan Med Ctr, Seoul, South Korea
关键词
OUTCOMES;
D O I
10.4093/dmj.2023.0038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:198 / 200
页数:3
相关论文
共 50 条
  • [1] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH SUBCLINICAL ATHEROSCLEROSIS MORE THAN NON-ALCOHOLIC FATTY LIVER DISEASE
    Park, Jung Gil
    Jang, Jaeyoung
    Lee, Yu Rim
    Kang, Min Kyu
    Jang, Se Young
    Kweon, Young-Oh
    Tak, Won Young
    Park, Soo Young
    GASTROENTEROLOGY, 2022, 162 (07) : S1212 - S1212
  • [2] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Tatsuki Uehara
    Hiromichi Wakui
    Kouichi Tamura
    Hypertension Research, 2023, 46 : 1165 - 1167
  • [3] Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
    Uehara, Tatsuki
    Wakui, Hiromichi
    Tamura, Kouichi
    HYPERTENSION RESEARCH, 2023, 46 (05) : 1165 - 1167
  • [4] Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
    Virk, Ghazala S.
    Vajje, Jaahnavi
    Virk, Nausheen K.
    Mannam, Raam
    Rehman, Wajeeh
    Ghobriel, Naglaa G.
    Mian, Irfan-ud-din
    Usama, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [5] Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
    Younossi, Zobair M.
    Paik, James M.
    Stepanova, Maria
    Ong, Janus
    Alqahtani, Saleh
    Henry, Linda
    JOURNAL OF HEPATOLOGY, 2024, 80 (05) : 694 - 701
  • [6] Non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: Conceptual changes for clinicians, researchers and patients
    Lin, Shuang Zhe
    Chen, Yuan Wen
    Fan, Jian Gao
    JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (11) : 604 - 609
  • [7] Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
    Colaci, Carmen
    Gambardella, Maria Luisa
    Scarlata, Giuseppe Guido Maria
    Boccuto, Luigi
    Colica, Carmela
    Luzza, Francesco
    Scarpellini, Emidio
    Mendez-Sanchez, Nahum
    Abenavoli, Ludovico
    HEPATOMA RESEARCH, 2024, 10
  • [8] Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort
    Cheng, Wei-Chun
    Chen, Hua-Fen
    Cheng, Hsiu-Chi
    Li, Chung-Yi
    EPIDEMIOLOGY AND HEALTH, 2024, 46 : e2024024
  • [9] Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?
    Kaya, Eda
    Zedginidze, Aleko
    Bechmann, Lars
    Canbay, Ali
    HEPATOBILIARY SURGERY AND NUTRITION, 2022, 11 (02) : 299 - 301
  • [10] Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
    Song, Byeong Geun
    Kang, Tae Wook
    Sinn, Dong Hyun
    Kim, Yeun-Yoon
    Min, Ji Hye
    Hwang, Jeong Ah.
    Shin, Jaeseung
    CLINICAL IMAGING, 2024, 108